Healthcare legislation company Frier Levitt has analyzed FDA enforcement actions versus “exploration only” peptide sellers. Their conclusion: the FDA considers a product’s classification dependant on its intended use, not its disclaimers. When Web-sites involve dosage guides, reconstitution Guidelines, or website link to forums talking about